Efficacy and Safety of Cryoballoon Ablation in Asymptomatic Patients with Atrial Fibrillation (ASYM study)

Miyamoto Koji0 个研究点目标入组 60 人开始时间: 2022年6月6日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients aged 20-85 years old
•2. Patients who atrial fibrillation was documented with 12-lead EGC within a year
•3. Patients diagnosed as asymptomatic atrial fibrillation
•4. Patients with written informed consent

•1. Patients with history of catheter ablation and/or surgery of atrial fibrillation
•2. Patients with left atrial dimension more than 55 mm
•3. Pregnant patients
•4. Patients with concomittant participation in intervention study with other medication and/or medical instrument
•5. Patients with active systemic infection
•6. Patients with thrombus in the heart
•7. Patients with cryoglobulinemia
•8. Patients after stent implantation at pulmonary veins
•9. Patients with LVEF <35%
•10. Patients with heart failure of NYHA III or iV
•11. Patients with any untreated or uncontrolled hyperthyroidism
•12. Patients with any untreated or uncontrolled hypothyroidism
•13. Patients with symptomatic carotid stenosis
•14. Patients with unstable angina pectoris
•15. Patients with myocardial infarction within 3 months proir to enrollment
•16. Patients with any condition contraindicating chronic anticoagulation
•17. Patients with myxoma
•18. Patients with severe renaly dysfunction (eGFR <15ml/min)
•19. Patients whom doctors responsible for this study judge inappropriate

发起方

Miyamoto Koji